Syncona Share News (SYNC)
SYNC Share
SYNC Share
SYNC Share
SYNC Share
SYNC
SYNC Share
SYNC Level 2
SYNC Live
SYNC Broker
SYNC Directors
SYNC Financial
SYNC
SYNC Short
SYNC
Last checked at -
To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out More
(Sharecast News) - Healthcare investment company Syncona reported year-end net assets of £1.3bn in its final results on Thursday, up from £1.25bn in the prior year.
Read more
UK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Syncona investee Freeline posts widened first quarter loss
Read moreLONDON MARKET CLOSE: Equities rally after shocking US jobs undershoot
Read moreLONDON MARKET MIDDAY: FTSE 100 hits 14-month high ahead of US jobs
Read moreSyncona investee Gyroscope postpones US IPO citing "market conditions"
Read more(Sharecast News) - Syncona portfolio company Gyroscope Therapeutics Holdings has postponed plans for its initial public offering in light of current market conditions, the healthcare firm said on Friday.
Read moreSyncona's Gyroscope Therapeutics progressing towards US float
Read moreSyncona's Gyroscope Therapeutics files for potential US IPO
Read moreIN BRIEF: Syncona director and CIO sell GBP1.6 million in shares
Read moreTRADING UPDATES: 4D Pharma loss widens on rise in administrative costs
Read moreSyncona says Achilles stake leaps to GBP145 million value after IPO
Read more(Sharecast News) - Syncona portfolio biopharma company Achilles Therapeutics said its US initial public offering (IPO) will raise $175.5m (£127.8mln).
Read moreDIRECTOR DEALINGS: Gym Group directors sell GBP1.8 million in shares
Read moreSyncona invests USD42 million into Gyroscope to have 54% stake
Read more
Last checked at